Table 1.

Patient characteristics

Number of patients14
Median age (range), y60.5 (37-89)
Hormone receptor status
ER/PR status
    Positive8
    Negative6
Her-2 status
    Positive4
    Negative10
Metastatic sites
    Brain1
    Lung, liver, bones2
    Lung2
    Pelvic and chest wall1
    Bone1
    Liver and bone2
    Distant nodes2
    Pleura and bone1
    Distant node and bone1
    Liver1
Prior line of systemic chemotherapy for MBC
    02
    15
    27
Prior systemic trastuzumab for MBC3
  • Abbreviation: PR, progesterone receptor.